Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease

Rev Port Cardiol. 2014 Mar;33(3):175.e1-4. doi: 10.1016/j.repc.2013.10.012. Epub 2014 Mar 27.

Abstract

Stress-induced cardiomyopathy, also known as 'broken heart syndrome' or Takotsubo cardiomyopathy, is characterized by transient systolic dysfunction of the apical and/or mid segments of the left ventricle, in the absence of significant coronary artery disease. We report the case of a 56-year-old male patient with chronic obstructive pulmonary disease (COPD), with stress-induced cardiomyopathy associated with the use of ipratropium bromide, administered in the context of an acute exacerbation of COPD.

Keywords: Brometo de ipratrópio; Cardiomiopatia de Takotsubo; Cardiomiopatia de stress; Ipratropium bromide; Stress cardiomyopathy; Takotsubo cardiomyopathy.

Publication types

  • Case Reports

MeSH terms

  • Bronchodilator Agents / adverse effects*
  • Bronchodilator Agents / therapeutic use
  • Humans
  • Ipratropium / adverse effects*
  • Ipratropium / therapeutic use
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Takotsubo Cardiomyopathy / chemically induced*

Substances

  • Bronchodilator Agents
  • Ipratropium